Yatharth Hospital & Trauma Care Services Limited
Yatharth Hospital & Trauma Care Services Limited, together with its subsidiaries, owns and operates super-specialty hospitals in India. The company offers services in the areas of medicine, cardiology, neurosciences, general surgery, nephrology and urology, pediatrics, gastroenterology, pulmonology, gynecology, orthopedics, spine and rheumatology, plastic and cosmetic surgery, ear, nose, throat, … Read more
Yatharth Hospital & Trauma Care Services Limited (YATHARTH) - Net Assets
Latest net assets as of March 2025: ₹16.37 Billion INR
Based on the latest financial reports, Yatharth Hospital & Trauma Care Services Limited (YATHARTH) has net assets worth ₹16.37 Billion INR as of March 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₹17.31 Billion) and total liabilities (₹940.45 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₹16.37 Billion |
| % of Total Assets | 94.57% |
| Annual Growth Rate | 74.35% |
| 5-Year Change | 1929.09% |
| 10-Year Change | N/A |
| Growth Volatility | 126.44 |
Yatharth Hospital & Trauma Care Services Limited - Net Assets Trend (2019–2025)
This chart illustrates how Yatharth Hospital & Trauma Care Services Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Yatharth Hospital & Trauma Care Services Limited (2019–2025)
The table below shows the annual net assets of Yatharth Hospital & Trauma Care Services Limited from 2019 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | ₹16.37 Billion | +87.25% |
| 2024-03-31 | ₹8.74 Billion | +377.87% |
| 2023-03-31 | ₹1.83 Billion | +56.53% |
| 2022-03-31 | ₹1.17 Billion | +44.87% |
| 2021-03-31 | ₹806.83 Million | +29.98% |
| 2020-03-31 | ₹620.72 Million | +6.58% |
| 2019-03-31 | ₹582.39 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Yatharth Hospital & Trauma Care Services Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1579.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₹3.62 Billion | 22.55% |
| Common Stock | ₹963.54 Million | 6.00% |
| Other Comprehensive Income | ₹9.87 Million | 0.06% |
| Other Components | ₹11.46 Billion | 71.39% |
| Total Equity | ₹16.05 Billion | 100.00% |
Yatharth Hospital & Trauma Care Services Limited Competitors by Market Cap
The table below lists competitors of Yatharth Hospital & Trauma Care Services Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Guangdong Chant Group Inc
SHE:002616
|
$271.83 Million |
|
Tianjin Tianyao Pharmaceuticals Co Ltd
SHG:600488
|
$271.83 Million |
|
Friend Co Ltd
SHG:605050
|
$271.87 Million |
|
Suzhou Jin Hong Shun Auto Parts Co Ltd Class A
SHG:603922
|
$271.96 Million |
|
ZJMI Environmental Energy Co. Ltd.
SHG:603071
|
$271.78 Million |
|
Chorus Aviation Inc
PINK:CHRRF
|
$271.74 Million |
|
Fila SpA
LSE:0QIQ
|
$271.70 Million |
|
Mainova AG
F:MNV6
|
$271.67 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Yatharth Hospital & Trauma Care Services Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 8,743,230,000 to 16,054,600,000, a change of 7,311,370,000 (83.6%).
- Net income of 1,305,500,000 contributed positively to equity growth.
- Other comprehensive income increased equity by 2,940,001.
- Other factors increased equity by 6,002,929,999.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₹1.31 Billion | +8.13% |
| Other Comprehensive Income | ₹2.94 Million | +0.02% |
| Other Changes | ₹6.00 Billion | +37.39% |
| Total Change | ₹- | 83.62% |
Book Value vs Market Value Analysis
This analysis compares Yatharth Hospital & Trauma Care Services Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.49x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 101.36x to 3.49x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-03-31 | ₹6.48 | ₹656.40 | x |
| 2020-03-31 | ₹6.32 | ₹656.40 | x |
| 2021-03-31 | ₹8.44 | ₹656.40 | x |
| 2022-03-31 | ₹13.61 | ₹656.40 | x |
| 2023-03-31 | ₹21.31 | ₹656.40 | x |
| 2024-03-31 | ₹110.44 | ₹656.40 | x |
| 2025-03-31 | ₹187.97 | ₹656.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Yatharth Hospital & Trauma Care Services Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.13%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 14.83%
- • Asset Turnover: 0.51x
- • Equity Multiplier: 1.08x
- Recent ROE (8.13%) is below the historical average (17.82%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 7.15% | 3.91% | 0.40x | 4.61x | ₹-15.83 Million |
| 2020 | -2.40% | -0.89% | 0.51x | 5.29x | ₹-67.30 Million |
| 2021 | 25.06% | 7.94% | 0.74x | 4.26x | ₹109.14 Million |
| 2022 | 37.78% | 11.01% | 0.94x | 3.64x | ₹324.74 Million |
| 2023 | 35.95% | 12.64% | 1.07x | 2.66x | ₹474.72 Million |
| 2024 | 13.09% | 17.07% | 0.66x | 1.17x | ₹270.43 Million |
| 2025 | 8.13% | 14.83% | 0.51x | 1.08x | ₹-299.96 Million |
Industry Comparison
This section compares Yatharth Hospital & Trauma Care Services Limited's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $12,693,693,925
- Average return on equity (ROE) among peers: 6.64%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Yatharth Hospital & Trauma Care Services Limited (YATHARTH) | ₹16.37 Billion | 7.15% | 0.06x | $271.79 Million |
| Apollo Hospitals Enterprise Limited (APOLLOHOSP) | $48.02 Billion | 3.13% | 1.38x | $8.72 Billion |
| Aster DM Healthcare Limited (ASTERDM) | $8.87 Billion | 5.90% | 0.85x | $1.48 Billion |
| Fortis Healthcare Limited (FORTIS) | $40.85 Billion | 1.77% | 2.04x | $4.64 Billion |
| GPT Healthcare Ltd (GPTHEALTH) | $2.18 Billion | 21.86% | 0.58x | $37.86 Million |
| Healthcare Global Enterprises Limited (HCG) | $2.96 Billion | -3.55% | 1.40x | $307.57 Million |
| Indraprastha Medical Corporation Limited (INDRAMEDCO) | $1.59 Billion | 16.95% | 1.52x | $183.78 Million |
| Jupiter Life Line Hospitals Limited (JLHL) | $2.37 Billion | 12.52% | 1.55x | $345.52 Million |
| Krishna Institute of Medical Sciences Limited (KIMS) | $14.11 Billion | 23.58% | 0.35x | $1.77 Billion |
| Lotus Eye Hospital and Institute Limited (LOTUSEYE) | $493.84 Million | -4.01% | 0.14x | $7.74 Million |
| Max Healthcare Institute Limited (MAXHEALTH) | $5.49 Billion | -11.78% | 1.33x | $7.97 Billion |